Status:
COMPLETED
A Single and Multiple-Dose Study of SB1578
Lead Sponsor:
S*BIO
Conditions:
Healthy Volunteer
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine the safety, tolerability, pharmacokinetics and pharmacodynamics of SB1578 in healthy volunteers.
Eligibility Criteria
Inclusion
- Healthy adult males and/or females of non-childbearing potential, 18 to 55 years of age (inclusive).
- Body mass index (BMI) ≥ 18.5 and ≤ 29.9 (kg/m2) and weight between 55 and 100 kg (inclusive).
- Medically healthy with clinically insignificant screening results.
Exclusion
- History or presence of significant disease.
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01235871
Start Date
August 1 2010
End Date
March 1 2011
Last Update
April 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Celerion
Tempe, Arizona, United States, 85283